Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

Focal segmental glomerulosclerosis associated with primary biliary cirrhosis.

Azak A, Koçak G, Huddam B, Koçak E, Ergül B, Duranay M.

Ren Fail. 2011;33(10):1052-3. doi: 10.3109/0886022X.2011.618971. No abstract available.

PMID:
22013944
2.

Behcet's disease and focal segmental glomerulosclerosis: an unusual association.

Granata A, Floccari F.

Rheumatol Int. 2012 Jun;32(6):1853-4. doi: 10.1007/s00296-011-2031-7. Epub 2011 Jul 22. No abstract available.

PMID:
21833522
3.

Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults.

Jafry N, Ahmed E, Mubarak M, Kazi J, Akhter F.

Nephrol Dial Transplant. 2012 Mar;27(3):1101-6. doi: 10.1093/ndt/gfr430. Epub 2011 Jul 29.

PMID:
21804085
4.

MYO1E, focal segmental glomerulosclerosis, and the cytoskeleton.

Ingelfinger JR.

N Engl J Med. 2011 Jul 28;365(4):368-9. doi: 10.1056/NEJMe1106093. Epub 2011 Jul 13. No abstract available. Erratum in: N Engl J Med. 2011 Aug 25;365(8):773.

PMID:
21751899
5.

Clinical trial of focal segmental glomerulosclerosis in children and young adults.

Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D'Agati VD, Friedman AL.

Kidney Int. 2011 Oct;80(8):868-78. doi: 10.1038/ki.2011.195. Epub 2011 Jul 6.

6.

Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.

Darouich S, Goucha R, Jaafoura MH, Zekri S, Ben Maiz H, Kheder A.

Ultrastruct Pathol. 2011 Aug;35(4):176-82. doi: 10.3109/01913123.2011.584657. Epub 2011 Jun 9. Review.

PMID:
21657818
7.

The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis.

Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ, Pang YS, Yang KP.

J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):624-33. doi: 10.1177/1470320311410584. Epub 2011 Jun 7. Review.

PMID:
21652690
8.

Focal segmental glomerulosclerosis after renal transplantation.

Shimizu A, Higo S, Fujita E, Mii A, Kaneko T.

Clin Transplant. 2011 Jul;25 Suppl 23:6-14. doi: 10.1111/j.1399-0012.2011.01452.x. Review.

PMID:
21623907
9.

How to treat corticosteroid-resistant idiopathic focal segmental glomerulosclerosis?

Rivera Hernández F.

Nefrologia. 2011;31(3):247-50. doi: 10.3265/Nefrologia.pre2011.Apr.10940. English, Spanish. No abstract available.

10.

Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.

Segarra Medrano A, Vila Presas J, Pou Clavé L, Majó Masferrer J, Camps Doménech J.

Nefrologia. 2011;31(3):286-91. doi: 10.3265/Nefrologia.pre2011.Feb.10870. Epub 2011 Mar 15. English, Spanish.

11.

Focal segmental glomerulosclerosis associated with invasive thymoma.

Yamauchi J, Ubara Y, Suwabe T.

Ther Apher Dial. 2011 Apr;15(2):210-1. doi: 10.1111/j.1744-9987.2010.00871.x. Epub 2010 Oct 25. No abstract available.

PMID:
21426517
12.

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.

Trachtman H, Fervenza FC, Gipson DS, Heering P, Jayne DR, Peters H, Rota S, Remuzzi G, Rump LC, Sellin LK, Heaton JP, Streisand JB, Hard ML, Ledbetter SR, Vincenti F.

Kidney Int. 2011 Jun;79(11):1236-43. doi: 10.1038/ki.2011.33. Epub 2011 Mar 2.

13.

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design.

Trachtman H, Vento S, Gipson D, Wickman L, Gassman J, Joy M, Savin V, Somers M, Pinsk M, Greene T.

BMC Nephrol. 2011 Feb 10;12:8. doi: 10.1186/1471-2369-12-8.

14.

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.

Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, Greene TH, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Middleton JP, Vehaskari VM, Hogan SL, Vento S, Flynn PA, Powell LM, McMahan JL, Siegel N, Friedman AL.

Kidney Int. 2011 Mar;79(6):678-685. doi: 10.1038/ki.2010.485. Epub 2010 Dec 22.

15.

Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.

Lee VW, Harris DC.

Nephrology (Carlton). 2011 Jan;16(1):30-8. doi: 10.1111/j.1440-1797.2010.01383.x. Review.

PMID:
21175974
16.

Plasma exchange and tacrolimus therapy for focal segmental glomerulosclerosis collapsing variant and the cytokine dynamics: a case report.

Kanai T, Shiraishi H, Ito T, Odaka J, Saito T, Aoyagi J, Ueda Y, Momoi MY.

Ther Apher Dial. 2010 Dec;14(6):603-5. doi: 10.1111/j.1744-9987.2010.00828.x. No abstract available.

PMID:
21118370
17.

Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.

Gbadegesin R, Lavin P, Foreman J, Winn M.

Pediatr Nephrol. 2011 Jul;26(7):1001-15. doi: 10.1007/s00467-010-1692-x. Epub 2010 Nov 26. Review.

18.

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

McCarthy ET, Sharma M, Savin VJ.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2115-21. doi: 10.2215/CJN.03800609. Epub 2010 Oct 21. Review.

19.

Focal segmental glomerulosclerosis: a very unusual complication of allogeneic hematopoietic cell transplantation (HCT).

Lopes JA, Martins C, Jorge S, Melo MJ, Resina C, Moreno R, do Carmo JA.

Bone Marrow Transplant. 2011 Jul;46(7):1019-20. doi: 10.1038/bmt.2010.222. Epub 2010 Sep 20. No abstract available.

PMID:
20856209
20.

Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome.

Ulinski T.

Curr Opin Organ Transplant. 2010 Oct;15(5):628-32. doi: 10.1097/MOT.0b013e32833dee3a. Review.

PMID:
20733489

Supplemental Content

Loading ...
Support Center